Skip to main content

David A D'Alessio

Lindquist McNeill Presidential Distinguished Chair
Medicine, Endocrinology, Metabolism, and Nutrition
DUMC Box 104775, Durham, NC 27710
300 North Duke Street, Durham, NC 27701

Scholarly Works - Conferences


198-OR: The Stimulatory Effect of Glucagon on Insulin Secretion Is Glucose Dependent in Healthy Human Subjects

Conference Diabetes · June 1, 2021 Glucagon is generally considered to be a counter-regulatory hormone with a primary role to raise blood glucose concentrations by increasing endogenous glucose production (EGP). However, recent preclinical findings support a paracrine action of gluc ... Full text Cite

229-LB: Quantification of GLP-1R Internalization and Recycling in Live ß Cells

Conference Diabetes · June 1, 2021 The glucagon-like peptide 1 receptor (GLP-1R) is a class B G-protein coupled receptor that is predominantly expressed on pancreatic β-cells in mice. Endogenous and synthetic ligands for GLP-1R exhibit distinct intracellular signaling cascades and p ... Full text Cite

781-P: Beyond Glucosuria: Urine Metabolome Signature Associated with Dapagliflozin in Wild-Type Mice

Conference Diabetes · June 1, 2021 Background: Glucosuria is a hallmark feature of diabetes. When blood glucose exceeds 200 mg/dl, the amounts reaching the renal tubule overwhelm the capacity of glucose transport and cause glucosuria. SGLT2 inhibitors (SGLT2i) prevent reclamation of ... Full text Cite

1016-P: A Novel GLP-1 and FGF-21 Dual Agonist Drug Protects Mice from Obesity and Hyperglycemia

Conference Diabetes · June 1, 2019 As the incidence of diabetes increases, the development of new therapeutic strategies is essential. Recent evidence supports combination therapies that incorporate complementary mechanisms of action as potent and effective. We have developed a unim ... Full text Cite

Intestinal hormones and regulation of satiety: the case for CCK, GLP-1, PYY, and Apo A-IV.

Conference JPEN J Parenter Enteral Nutr · 2008 Satiety, the physiologic processes that combine to bring about the cessation of a meal, is controlled in part by intestinal peptide secretion. The effects of cholecystokinin, glucagon-like peptide I, peptide YY, and apolipoprotein A-IV are described. ... Full text Link to item Cite

Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.

Conference J Clin Endocrinol Metab · June 2004 Previous studies indicate that leptin secretion is regulated by insulin-mediated glucose metabolism. Because fructose, unlike glucose, does not stimulate insulin secretion, we hypothesized that meals high in fructose would result in lower leptin concentrat ... Full text Link to item Cite

Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis.

Conference J Gastrointest Surg · December 2003 Autologous islet cell transplantation after near-total or total pancreatic resection can alleviate pain in patients with severe chronic pancreatitis and preserve endocrine function. From February 2000 to February 2003, a total of 22 patients, whose median ... Full text Link to item Cite

Glucagon-like peptide 1 (GLP-1) in diabetes and aging

Conference Journal of Anti Aging Medicine · January 1, 2000 Glucagon-like peptide 1 (GLP-1) is an intestinal hormone that is secreted after meals and augments insulin secretion in response to absorbed glucose. Experiments in animals have demonstrated that GLP-1 is necessary for normal glucose tolerance. GLP-1 is ef ... Full text Cite

Effects of GLP-1 [9-36] NH2, a metabolite of GLP-1 [7-36] NH2, on insulin secretion in Hamster Insulinoma Tumor (HIT) cells

Conference Investigative Ophthalmology and Visual Science · February 15, 1996 GLP-1 [7-36] NH2 (GLP-1) is a potent insulin secretagogue released from the GI tract after meals. GLP-1 is rapidly metabolized to GLP-1 [9-36] NH2 in the circulation, and this truncated form is the predominant GLP-1 species in post-pr ... Cite